Discontinued — last reported Q3 '25
Equity Residential Equity Method Investments decreased by 0.1% to $325.57M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 21.0%, from $411.97M to $325.57M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 43.9% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $53.36M | $79.43M | $127.45M | $150.09M | $169.27M | $256.31M | $279.02M | $292.28M | $304.71M | $313.23M | $282.05M | $289.27M | $341.87M | $359.81M | $386.53M | $411.97M | $403.77M | $400.08M | $325.94M | $325.57M |
| QoQ Change | — | +48.8% | +60.5% | +17.8% | +12.8% | +51.4% | +8.9% | +4.8% | +4.3% | +2.8% | -10.0% | +2.6% | +18.2% | +5.2% | +7.4% | +6.6% | -2.0% | -0.9% | -18.5% | -0.1% |
| YoY Change | — | — | — | — | +217.2% | +222.7% | +118.9% | +94.7% | +80.0% | +22.2% | +1.1% | -1.0% | +12.2% | +14.9% | +37.0% | +42.4% | +18.1% | +11.2% | -15.7% | -21.0% |